We are live on !
Find out more
BCM
Bratton Capital Management Portfolio holdings
AUM
$40.8M
Turnover
0%
1-Year Est. Return
25.68%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+25.68%
3 Year Est. Return
+152.12%
5 Year Est. Return
+4.79%
10 Year Est. Return
–
AUM
$40.8M
AUM Growth
+$98.1K
(+0.24%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
7.5
years
Top 10 Avg Time Held
7.5
years
Top 20 Avg Time Held
7.5
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Aquestive Therapeutics
AQST
$466M
| $40.8M | 100% |
9,810,958
| – | – |
2018 Q4
30 quarters
|
|
Similar funds
DVF
Bratton Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Bratton Capital Management held 1 position worth $40.8M, up 0.24% from $40.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 0%. Bratton Capital Management opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Bratton Capital Management's ten largest holdings make up 100% of its $40.8M portfolio in Q2 2026.
- Bratton Capital Management opened 0 new positions and closed 0 in Q2 2026.
- Bratton Capital Management's portfolio value rose 0.24% quarter-over-quarter to $40.8M.
Based on Bratton Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.